Fatemeh Haddadi | Pharmaceutical Biotechnology | Best Researcher Award

Dr. Fatemeh Haddadi | Pharmaceutical Biotechnology | Best Researcher Award

University of Zabol | Iran

Dr. Fatemeh Haddadi is a distinguished Iranian scientist and academic, recognized for her pioneering contributions to plant biotechnology, nanobiotechnology, genetic engineering, and molecular genetics. She earned her Bachelor of Science in Plant Biology from the University of Zabol, followed by both her Master’s and Ph.D. degrees in Plant Biotechnology from Universiti Putra Malaysia. Over the years, she has established herself as an influential figure in academia and research, combining advanced molecular methods with applied biotechnology to address agricultural and biomedical challenges.Dr. Haddadi began her academic career as a Special Graduate Research Assistant at Universiti Putra Malaysia, where she actively contributed to groundbreaking research in plant tissue culture and molecular biology. Upon returning to Iran, she joined the University of Zabol as an Assistant Professor, where she continues to teach and supervise both undergraduate and postgraduate students in subjects such as genetics, molecular genetics, genetic engineering, molecular biology, animal biotechnology, and bioinformatics. Her mentorship has guided dozens of graduate students, helping to shape the next generation of biotechnologists.In addition to her academic roles, Dr. Haddadi serves as the Head of Zand Biotechnology Company, a knowledge-based enterprise specializing in biotechnology and genetic engineering innovations. Under her leadership, the company has developed several advanced biotechnological products, including DNA isolation kits from gel, blood, and plants, which have achieved Technology Readiness Level (TRL) 7 recognition by Iran’s national technology assessment authority. Her dedication to translational research bridges the gap between laboratory discovery and industrial application, emphasizing practical solutions for real-world scientific needs.Dr. Haddadi’s innovative spirit has been recognized with several prestigious accolades, including the Khwarizmi Award, multiple medals from the PRPI Invention, Research and Innovation Exhibition, and national awards for knowledge-based products and scientific entrepreneurship. Her scientific influence extends through an impressive portfolio of peer-reviewed publications, including research on micropropagation of strawberry, Agrobacterium-mediated transformation, and the development of gold nanoparticle-based biosensors for molecular detection and gene transformation.

Profile: Google Scholar

Featured Publications

Haddadi, F., Abd Aziz, M., Saleh, G., Abd Rashid, A., & Kamaladini, H. (n.d.). Micropropagation of strawberry cv. Camarosa: Prolific shoot regeneration from in vitro shoot tips using thidiazuron with N6-benzylamino-purine. HortScience, 45(3), 453–456.

Khodavirdipour, A., Haddadi, F., & Keshavarzi, S. (n.d.). Chromium supplementation; negotiation with diabetes mellitus, hyperlipidemia and depression. Journal of Diabetes & Metabolic Disorders, 19(1), 585–595.

Ahmadi, S., Kamaladini, H., Haddadi, F., & Sharifmoghadam, M. R. (n.d.). Thiol-capped gold nanoparticle biosensors for rapid and sensitive visual colorimetric detection of Klebsiella pneumoniae. Journal of Fluorescence, 28(4), 987–998.

Haddadi, F., Abd Aziz, M., Abdullah, S. N. A., Tan, S. G., & Kamaladini, H. (n.d.). An efficient Agrobacterium-mediated transformation of strawberry cv. Camarosa by a dual plasmid system. Molecules, 20(3), 3647–3666.

Haddadi, F., Abd Aziz, M., Kamaladini, H., & Ravanfar, S. A. (n.d.). Thidiazuron- and zeatin-induced high-frequency shoot regeneration from leaf and shoot-tip explants of strawberry. HortTechnology, 23(3), 276–281.

Ravanfar, S. A., Abd Aziz, M., Abd Kadir, M., Abd Rashid, A., & Haddadi, F. (n.d.). In vitro adventitious shoot regeneration and acclimatisation of Brassica oleracea subsp. italica cv. Green Marvel. African Journal of Biotechnology, 10(29), 5614–5619.

Osmani Bojd, M., Kamaladini, H., Haddadi, F., & Vaseghi, A. (n.d.). Thiolated AuNP probes and multiplex PCR for molecular detection of Staphylococcus epidermidis. Molecular and Cellular Probes, 34, 30–36.

Basavaraj Vastrad | Pharmaceutical Biotechnology | Best Innovation Award

Dr. Basavaraj Vastrad | Pharmaceutical Biotechnology | Best Innovation Award

Associate Professor at KLE College of Pharmacy | India

Dr. Basavaraj Vastrad is a distinguished researcher in biochemistry, pharmaceutical biotechnology, and bioinformatics, with expertise spanning drug discovery, biomarker identification, molecular biology, and microbial techniques. His academic journey and scientific contributions reflect a strong commitment to advancing medical and pharmaceutical sciences. He has made significant strides in bioinformatics-driven research, particularly in understanding neurodegenerative and metabolic diseases through next-generation sequencing and computational biology approaches. With a strong foundation in microbiology, tissue culture, and molecular techniques, Dr. Vastrad bridges experimental science with computational tools. His research has resulted in impactful publications, addressing global health challenges and advancing translational medicine.

Publication Profile 

Google Scholar

Education 

Dr. Basavaraj Vastrad earned his Ph.D. in Biochemistry from Kuvempu University, where he focused on antibiotic production and optimization using solid-state fermentation. He holds an M. Pharm in Pharmaceutical Biotechnology from J.S.S. College of Pharmacy, Ootacamund, affiliated with The Tamilnadu Dr. M.G.R Medical University, where he gained expertise in microbial, molecular, and tissue culture techniques. He began his academic foundation with a B. Pharmacy degree from K.L.E’s College of Pharmacy under RGUHS, Bangalore. Earlier, he completed his P.U.C-II at Karnataka Science College, Dharwad, and his S.S.L.C. at Karnataka High College, Dharwad, establishing a solid base in science and medicine.

Experience 

Dr. Basavaraj Vastrad has extensive research experience in pharmaceutical biotechnology, biochemistry, and bioinformatics. His M. Pharm work encompassed microbial assays, enzyme characterization, fermentation technology, cytotoxicity studies, antiviral and antioxidant assays, and tissue culture methods. During his doctoral program, he investigated solid-state fermentation for antibiotic production using agricultural residues, optimizing growth conditions and characterizing bioactive compounds through advanced analytical methods. His expertise extends to next-generation sequencing, microarray analysis, and biomarker discovery, contributing to translational research in neurodegenerative and metabolic diseases. Through bioinformatics-driven projects, Dr. Vastrad has made critical discoveries in molecular pathways and therapeutic targets, resulting in several impactful publications.

Awards and Honors 

Dr. Basavaraj Vastrad has been recognized for his contributions to pharmaceutical biotechnology, bioinformatics, and biomedical research. His work on disease biomarker identification and next-generation sequencing analysis has earned appreciation in the scientific community, leading to high-quality publications in reputed international journals. His doctoral research on antibiotic production through solid-state fermentation was highly regarded for its potential industrial applications. He has also been acknowledged for his collaborative research on Alzheimer’s, Parkinson’s, Huntington’s disease, and metabolic disorders. With impactful publications, peer recognition, and contributions to translational science, Dr. Vastrad stands as a promising candidate for research awards and academic distinction.

Research Focus 

Dr. Basavaraj Vastrad research focuses on the intersection of biotechnology, molecular biology, and bioinformatics. His expertise lies in identifying disease-associated genes, pathways, and biomarkers through computational and next-generation sequencing data analysis. He has explored the molecular underpinnings of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, Huntington’s disease, dementia, and metabolic disorders like gestational diabetes mellitus. His doctoral research emphasized antibiotic production through solid-state fermentation, while his M. Pharm training provided strong grounding in microbial, enzymatic, and cell culture techniques. Currently, his bioinformatics-driven studies integrate systems biology with molecular docking to propose potential therapeutic compounds for complex human diseases.

Publication Top Notes

Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data

Optimization and production of neomycin from different agro industrial wastes in solid state fermentation

Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis

Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19

Identification of crucial candidate genes and pathways in glioblastoma multiform by bioinformatics analysis

Optimization of process parameters for rifamycin b production under solid state fermentation from Amycolatopsis mediterranean MTCC14

Identification of potential mRNA panels for severe acute respiratory syndrome coronavirus 2 (COVID-19) diagnosis and treatment using microarray dataset and bioinformatics methods

Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules

Identification of important invasion and proliferation related genes in adrenocortical carcinoma

Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules

Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis

Identification of key pathways and genes in obesity using bioinformatics analysis and molecular docking studies

Analysis of differentially expressed genes in coronary artery disease by integrated microarray analysis

Conclusion

Based on his strong academic foundation, diverse methodological expertise, and influential research publications in neurodegenerative, metabolic, and reproductive disorders, Dr. Basavaraj Vastrad is a highly suitable candidate for the Research for Best Innovation Award. His pioneering bioinformatics-driven approaches to unravel disease mechanisms and identify biomarkers showcase a forward-thinking vision aligned with global health challenges. With additional focus on translational research and clinical applications, he has the potential to emerge as a leading innovator in pharmaceutical biotechnology and precision medicine.